NCT07787273
- Conditions
- Camrelizumab, Locally Advanced Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy
- Locations
-
- Hefei Cancer Hospital, Chinese Academy of Sciences Hefei, Anhui, China
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China